- In recent weeks, intuitive surgical procedures have expanded the new AI-powered Da Vinci 5 system, showcasing successful remote science demonstrations over 4,000 miles, securing regulatory approval in Europe, Japan and South Korea, and promoting an international growth footprint.
- Particularly important developments are the 88% year-on-year increase in single-port (SP) surgical procedures and the increased new clearance for colorectal applications, highlighting the accelerated global adoption of advanced surgical techniques of intuition.
- We'll explore how the launch of the feature of the advanced AI-powered Da Vinci 5 reconstructs the intuitive long-term investment narrative of surgical.
Explore 26 top quantum computing companies that will lead the next-generation technology revolution and shape the future with quantum algorithms, superconducting Qubits and cutting-edge research breakthroughs.
An intuitive surgical investment story summary
To become an intuitive surgical shareholder, I believe in the continuous expansion of minimally invasive robot-assisted surgery and the continued expansion of the company's powerful product innovation pipeline. The latest wave of AI-driven Da Vinci 5 features and powerful international regulatory victory could support future adoption rates, but in the short term, tariff-related cost pressures remain the most important risk of profitability. Recent news does not mitigate that risk or even overturn the key catalysts for the growth of global procedures.
In a recent announcement, the 88% increase in surgical procedures and expanded regulatory clearance of single-port platforms, particularly for new colorectal applications, is particularly relevant, and directly supports the narrative of adoption of accelerated systems as catalysts. This growth reflects an increase in global use, strengthening cases of intuitive surgical roles in expanding complex procedures portfolios and could support higher repetitive revenue streams, even if cost challenges continue.
In contrast, investors should note that increased tariffs and associated trade uncertainty may still affect margins…
Read the complete intuitive surgical story (free!)
The intuitive surgical outlook predicts revenue of $13.4 billion and profit of $3.7 billion by 2028. This is based on a 13.5% increase in revenue from current levels of $2.6 billion and a $1.1 billion increase.
An intuitive Surgical forecast reveals how to get a fair value of $582.10.
Explore other perspectives
Estimates of 15 individual fair value from the Simply Wall St community for an intuitive surgical range of USD 272 to USD 582 per share. While many focus on moving forward recruitment and regulatory clearance as a growth signal, you can explore different perspectives on the company's outlook.
Explore 15 other fair value estimates on intuitive surgical – why inventory is worth 29% higher than current prices!
Build your own intuitive surgical story
Do you oppose existing stories? Create your own creation within 3 minutes – extraordinary investment returns rarely come from following the flock.
- A great starting point for your intuitive surgical research is an analysis that highlights three important rewards that can affect your investment decisions.
- Free, intuitive surgical research reports provide comprehensive basic analysis, summarized in a single visual (snowflake).
Are you interested in other possibilities?
The market won't wait. These fast stocks are hot now. Grab the list before they run:
This article simply by Wall Street is inherently common. We provide commentary based on historical data and analyst forecasts, and use impartial methodologies, and our articles are not intended for financial advice. It is not a recommendation to buy or sell stocks and does not take into account your goals or financial situation. We aim to deliver long-term intensive analysis driven by basic data. Please note that the analysis may not take into account the latest price-sensitive company announcements and qualitative material. Simply put, the Wall ST has no position in the stock mentioned.
new: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to reveal opportunities.
•Dividend Powerhouse (yield of 3% or more)
Underrated small cap with insider purchases
High-growth technology and AI companies
Or create your own from over 50 metrics.
Explore now for free
Do you have feedback in this article? Are you worried about the content? Please contact us directly. Alternatively, please email editorial-team@simplywallst.com
